Add BrightSurf on Google Email

Making next-generation preconception screening a reality for parents

A recent clinical study found that most parents-to-be want access to information from preconception carrier screening, including genetic variants associated with common disorders. However, the interpretation of these variants remains a significant challenge due to limited knowledge about their effects on health.

SourceCell Press·JournalAmerican Journal of Human Genetics·DateMay 10, 2018

NIH researchers crack mystery behind rare bone disorder

Researchers have identified the genetic basis of melorheostosis, a rare bone disorder characterized by excess bone formation resembling dripping candle wax. The study found that mutations in the MAP2K1 gene were responsible for the condition, offering potential treatment targets and insights into bone development.

ALS, rare dementia share genetic link

Researchers have identified genetic links between ALS and frontotemporal dementia, suggesting that treatments for one may also work for the other. The study found common genetic variations associated with both disorders, including those near the MAPT gene and BNIP1.

SourceWashU Medicine·JournalJAMA Neurology·DateApr 9, 2018

Genetics researchers close in on schizophrenia

Researchers have discovered 50 new gene regions increasing schizophrenia risk, including genes previously associated with intellectual disability and autism. These findings shed light on the disorder's complex genetics, suggesting subtle genetic variants can contribute to its development.

SourceCardiff University·JournalNature Genetics·DateFeb 27, 2018

Scientists move closer to treatment for Huntington's disease

Researchers have developed a safer and more specific CRISPR/Cas9 system to treat Huntington's disease, a neurodegenerative disorder caused by a defective gene. The new technique successfully inactivates the mutant gene and reduces toxic protein synthesis, offering hope for a potential cure.

SourceFrontiers·JournalFrontiers in Neuroscience·DateFeb 26, 2018

Letting silenced genes speak

Researchers at UConn Health have reversed Prader-Willi syndrome in lab-grown brain cells by targeting the ZNF274 protein, which silences many genes. The breakthrough provides clues for treating this genetic disorder and offers new hope for patients with life-threatening childhood obesity.

SourceUniversity of Connecticut·JournalHuman Molecular Genetics·DateJan 25, 2018

Study examines link between epilepsy and mood disorders

A new study suggests a shared genetic susceptibility between epilepsy and mood disorders, particularly in individuals with focal epilepsy. The study found a significant increase in lifetime prevalence of mood disorders among people with focal epilepsy compared to those with generalized epilepsy.

SourceWiley·JournalEpilepsia·DateJan 11, 2018

First discover the disorder and then find the patients

Scientists at Bielefeld University confirm the presence of a previously unknown genetic defect 'MPS III-E' causing progressive blindness and inner ear hearing impairment in patients. Biochemical studies revealed that the disorder is caused by an enzyme deficiency, which can be treated with biotechnological enzyme replacement therapy.

SourceBielefeld University·JournalGenetics in Medicine·DateJan 5, 2018

Creating brain cells to detect Tourette's

Researchers at Rutgers University created brain cells from blood samples of individuals in a three-generation family with Tourette syndrome. The study found that a mutation in the PNKD gene is likely the cause of the disorder, which affects one in every 100-150 people in the US.

SourceRutgers University·JournalMolecular Psychiatry·DateSep 25, 2017

Spark Therapeutics announces publication in The Lancet of pivotal Phase 3 clinical trial data for investigational voretigene neparvovec

The Phase 3 clinical trial data showed statistically significant and clinically meaningful improvements in functional vision and visual field in participants with RPE65-mediated inherited retinal disease. Participants demonstrated marked gains in full-field light sensitivity and peripheral vision.

SourceTen Bridge Communications·JournalThe Lancet·DateJul 14, 2017